AT119393T - Use of an opiate antagonist medicament to be administered transdermally for the production of a well as a device for transdermal administration. - Google Patents

Use of an opiate antagonist medicament to be administered transdermally for the production of a well as a device for transdermal administration.

Info

Publication number
AT119393T
AT119393T AT90122076T AT90122076T AT119393T AT 119393 T AT119393 T AT 119393T AT 90122076 T AT90122076 T AT 90122076T AT 90122076 T AT90122076 T AT 90122076T AT 119393 T AT119393 T AT 119393T
Authority
AT
Austria
Prior art keywords
production
well
use
device
transdermal administration
Prior art date
Application number
AT90122076T
Other languages
German (de)
Inventor
John David Sinclair
Original Assignee
Alko Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/439,050 priority Critical patent/US5096715A/en
Application filed by Alko Ltd filed Critical Alko Ltd
Publication of AT119393T publication Critical patent/AT119393T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/81Addiction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/81Addiction
    • Y10S514/811Alcohol
AT90122076T 1989-11-20 1990-11-19 Use of an opiate antagonist medicament to be administered transdermally for the production of a well as a device for transdermal administration. AT119393T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/439,050 US5096715A (en) 1989-11-20 1989-11-20 Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist

Publications (1)

Publication Number Publication Date
AT119393T true AT119393T (en) 1995-03-15

Family

ID=23743078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90122076T AT119393T (en) 1989-11-20 1990-11-19 Use of an opiate antagonist medicament to be administered transdermally for the production of a well as a device for transdermal administration.

Country Status (10)

Country Link
US (1) US5096715A (en)
EP (1) EP0429039B1 (en)
AT (1) AT119393T (en)
AU (1) AU639042B2 (en)
CA (1) CA2030237C (en)
DE (2) DE69017596T2 (en)
DK (1) DK0429039T3 (en)
ES (1) ES2074513T3 (en)
FI (1) FI905718A (en)
NZ (2) NZ247173A (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
DE4223004A1 (en) * 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Pharmaceutical semi-solid topical dosage form for transdermal
US5580876A (en) * 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
USRE36547E (en) * 1992-09-21 2000-02-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
US6096756A (en) 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
DE4423850A1 (en) * 1994-07-07 1996-01-11 Labtec Gmbh Transdermal delivery device for naloxone hydrochloride
US5587381A (en) * 1995-03-27 1996-12-24 Sinclair; John D. Method for terminating methadone maintenance through extinction of the opiate-taking responses
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
CN1234362C (en) 1997-12-22 2006-01-04 欧罗赛铁克股份有限公司 Opioid agonist/antagonist combinations
JP2001526229A (en) 1997-12-22 2001-12-18 ユーロ−セルティーク,エス.エイ. Method of preventing abuse of opioid dosage forms
US20060121103A1 (en) * 2000-05-11 2006-06-08 Kenneth Kirby Transdermal delivery system
EP1094781B1 (en) 1998-07-07 2008-07-02 Transdermal Technologies Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
EP1248800A2 (en) * 1999-11-30 2002-10-16 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
PT1255547E (en) * 2000-02-08 2008-11-24 Euro Celtique Sa Controlled-release compositions containing opioid agonist and antagonist
US6569449B1 (en) 2000-11-13 2003-05-27 University Of Kentucky Research Foundation Transdermal delivery of opioid antagonist prodrugs
US20040024004A1 (en) * 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
CN1525851A (en) 2001-05-11 2004-09-01 恩德制药公司 Abuse-resistant controlled-release opioid dosage form
CN1273075C (en) * 2001-07-13 2006-09-06 爱科来株式会社 Analyzing apparatus, piercing element integrally installed body for temperature measuring device with analyzing apparatus, and body fluid sampling apparatus
PT1416842E (en) * 2001-07-18 2009-03-31 Euro Celtique Sa Pharmaceutical combinations of oxycodone and naloxone
JP4504013B2 (en) 2001-08-06 2010-07-14 ユーロ−セルティーク エス.エイ. Opioid agonist formulation having a releasable and sequestered antagonist
WO2003013433A2 (en) * 2001-08-06 2003-02-20 Euro-Celtique S.A. Sequestered antagonist formulations
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
RU2004107501A (en) * 2001-08-14 2005-02-20 Байотай Терапис Корпорейшн (Fi) A method of treating alcoholism or alcohol abuse
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
EP2425824B1 (en) 2002-04-05 2017-05-10 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
ES2677769T3 (en) 2002-09-20 2018-08-06 Alpharma Pharmaceuticals Llc Sequestering subunit and related compositions and procedures
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
CA2522471A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
US20060009478A1 (en) * 2003-10-15 2006-01-12 Nadav Friedmann Methods for the treatment of back pain
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1809104A4 (en) * 2004-09-23 2009-04-29 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US7910599B2 (en) 2005-01-10 2011-03-22 John David Sinclair Method for treating eating disorders by selective extinction with transdermal naloxone
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
JP5566102B2 (en) 2006-06-19 2014-08-06 アルファーマ ファーマシューティカルズ エルエルシー Pharmaceutical composition
JP2010531807A (en) 2007-05-25 2010-09-30 トルマー セラピューティクス, インコーポレイテッド Sustained release delivery formulation of risperidone compound
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
JP2011513287A (en) * 2008-02-28 2011-04-28 シントロファーマ リミテッドSyntropharma Limited Pharmaceutical compositions
SI2317991T1 (en) * 2008-07-07 2017-09-29 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
DK2405915T3 (en) 2009-03-10 2019-02-11 Euro Celtique Sa Pharmaceutical compositions with immediate release including oxycodon and naloxon
WO2011064769A1 (en) 2009-11-24 2011-06-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and pharmaceutical compositions for the treatment of hot flashes
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
CA2918004C (en) 2013-07-23 2018-11-20 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2837881A (en) * 1952-12-13 1958-06-10 Lawrence A Schneider Encapsulated product and method and apparatus for making same
US3249109A (en) * 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
US4629539A (en) * 1982-07-08 1986-12-16 Tdk Corporation Metal layer patterning method
JPS59501712A (en) * 1982-08-25 1984-10-11
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
DE3545926C2 (en) * 1985-12-23 1989-03-02 Allan Gerhard 8047 Karlsfeld De Fruehauf
ES2042527T3 (en) * 1986-11-14 1993-12-16 Theratech Inc A method for preparing a pharmaceutical composition augmentary penetration for topical application.
DE3862405D1 (en) * 1987-03-09 1991-05-23 Alza Corp Composition for the prevention of a contact allergy by simultaneously administering a corticosteroid to a sensiblisierenden drug.
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response

Also Published As

Publication number Publication date
AU639042B2 (en) 1993-07-15
NZ236104A (en) 1993-04-28
CA2030237A1 (en) 1991-05-21
AU6665090A (en) 1991-05-23
DE69017596T2 (en) 1995-07-06
FI905718A (en) 1991-05-21
US5096715A (en) 1992-03-17
EP0429039A2 (en) 1991-05-29
EP0429039A3 (en) 1991-10-16
ES2074513T3 (en) 1995-09-16
DE69017596D1 (en) 1995-04-13
CA2030237C (en) 1997-12-30
FI905718D0 (en)
EP0429039B1 (en) 1995-03-08
FI905718A0 (en) 1990-11-20
NZ247173A (en) 1997-07-27
DK0429039T3 (en) 1995-03-27

Similar Documents

Publication Publication Date Title
DE3787977T2 (en) Arrangement for self-administration of physiologically active substances under prevention of overdose.
DE69009131D1 (en) Pre-slit injection device and conical cannula.
FR2602423B1 (en) Method of preparing a medicament based on fenofibrate, drug obtained by this method
NO177140C (en) A process for the preparation of substituted pyridyl-dihydroxy-heptenoic acid and salts thereof as well as intermediates for use in the method
DE69104223T2 (en) A process for the preparation of taxane derivatives, thus obtained new derivatives and pharmaceutical compositions containing them.
DE2950977A1 (en) Novel pharmaceutical preparation form for oral administration of drugs with programmed occupation, as well as methods for their production
ATA203688A (en) A process for the preparation of solutions of cellulose, as well as means for carrying out the method
DE3751121D1 (en) Device for the transcutaneous administration of medicines.
DE68907858T2 (en) Drug formulations for transdermal administration of drugs.
ATA86885A (en) A method for manufacturing storage-stable, rapidly disintegrating pharmaceutical drug compacts
AT319447T (en) Pharmaceutical preparations The clavulanic acid or derivatives to behandlund of neurological disorders
DE3769812D1 (en) Using phosphordiesteraseinhibitoren and cyclic nucleotide analogs for the manufacture of a medicament for stimulating tear secretion.
DE2822544A1 (en) New pharmaceutically active compounds, methods for their production and drug
DE3856306D1 (en) A process for producing applicators for transdermal administration of drugs
AT204162T (en) A process for the preparation of drug formulations in the form of a solid solution of the drug in a polymer matrix
NO934523D0 (en) Method of adjusting the saturation concentration of a drug for transdermal administration template
AT18397T (en) Benzazepin-2-one, processes for their preparation, pharmaceutical compositions containing these compounds and the compounds for therapeutic use.
DE69419822T2 (en) A device for heart function analysis to determine whether a tachyarrhythmia may be interrupted by stimulation
DE69029273D1 (en) Effervescent dosage form and methods for their administration
DE68915132D1 (en) A process for the treatment of periodontal disease by protracted drug delivery of pharmaceuticals in the tooth cavity, composition thereof and a device for administration.
DE3876877T2 (en) Using indolone-derivatives for the manufacture of medicines to treat Parkinson's disease.
DE3775830D1 (en) Activation of a transdermal drug delivery system by moisture.
AT98530T (en) Ultrasonic array with trapezfoermigen schwinger elements as well as process and apparatus for its production.
DE3579631D1 (en) Drugs with poorly soluble active ingredients and methods for its production.
NO903792D0 (en) A tampon for medical or hygiensike purposes as well as process for their preparation.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time